Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus

Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus

(2020) Elisabet Svenungsson et al.   RHEUMATOLOGY

Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome

(2019) Paola Adele Lonati et al.   Frontiers in Immunology

The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System

(2019) Oskar Eriksson et al.   Frontiers in Immunology

Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015

(2018) Eric Y. Yen et al.   Arthritis & Rheumatology

Cell-bound complement activation products (CB-CAPs) have high sensitivity and specificity in pediatric-onset systemic lupus erythematosus and correlate with disease activity

(2018) J S Hui-Yuen et al.   LUPUS

Platelet-Mediated Thrombosis

(2016) Paul A. Gurbel et al.   CIRCULATION RESEARCH

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis

(2015) Kim L.L. Habets et al.   ARTHRITIS RESEARCH & THERAPY

Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System on Platelets in Systemic Lupus Erythematosus

(2014) Christian Lood et al.   PLoS One

Persistent enhanced platelet activation in patients with acute myocardial infarction and coronary microvascular obstruction: clinical implications

(2013) C. Aurigemma et al.   THROMBOSIS AND HAEMOSTASIS

Overall and Cause-Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta-Analysis of Observational Studies

(2013) Marko Yurkovich et al.   ARTHRITIS CARE & RESEARCH

Relation of Platelet C4d with All-Cause Mortality and Ischemic Stroke in Patients with Systemic Lupus Erythematosus

(2013) Amy H Kao et al.   Translational Stroke Research

Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

(2012) L. S. Magder et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

FcγRIIa Ligation Induces Platelet Hypersensitivity to Thrombotic Stimuli

(2012) Mark D. Berlacher et al.   AMERICAN JOURNAL OF PATHOLOGY

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus

(2012) Kenneth C. Kalunian et al.   ARTHRITIS AND RHEUMATISM

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus – a possible link to venous thrombosis?

(2012) C Lood et al.   LUPUS

Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus

(2010) Amy H. Kao et al.   ARTHRITIS AND RHEUMATISM

Platelet CD154 Potentiates Interferon-  Secretion by Plasmacytoid Dendritic Cells in Systemic Lupus Erythematosus

(2010) P. Duffau et al.   Science Translational Medicine

Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpura

(2009) Ellinor I. B. Peerschke et al.   BRITISH JOURNAL OF HAEMATOLOGY

Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies

(2009) EIB Peerschke et al.   LUPUS